500 patients67,039 observations150 daysLIVE

Emergent Cluster EC-01NEW

45 patients

Response builds, then fades from the second month without a toxicity signal.

Emerges around
Day 75
Detectable by LIFE OS
Day 57
Median clinical recognition
Day 108
Potential lead time
51 days

Average trajectory of the cluster

mean of 45 trajectories · dashed = model expectation at baseline
solid = observed · dashed = predicted

Shared signals

  • response plateau by day ~35
  • no toxicity signal
  • adherence drift after day ~70
  • declining step count
Mean response
39
Mean GI score
19
Discontinuation risk
20%

Potential action

AD-05 appears associated with improved persistence among similar patients (+14% persistence, −2% symptom burden in synthetic history).

Members